http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104353063-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-54 |
| filingDate | 2014-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104353063-B |
| titleOfInvention | Prevention and the biological agent and preparation method of control human respiratory syncytial virus's infection |
| abstract | The present invention relates to a kind of novel antiviral biological agent of pharmaceutical technology field, a kind of biological agent and preparation method for preventing and controlling human respiratory syncytial virus's infection is specifically related to.The present invention is Globulins cell entry/fusion inhibitor.It acts on the first stage of poisoning intrusion target cell, has blocked infection of the virus to cell, so as to reach the effect of prevention and control virus.A kind of positively charged amino acid of protein surface for separating and purifying is modified using a kind of activity anhydride, blocks human respiratory syncytial virus RSV to enter the function with target cell infection so as to make it have. |
| priorityDate | 2014-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 219.